<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03432377</url>
  </required_header>
  <id_info>
    <org_study_id>P16/17_COCANASH</org_study_id>
    <secondary_id>2016-A01872-49</secondary_id>
    <nct_id>NCT03432377</nct_id>
  </id_info>
  <brief_title>Coffee Consumption and NASH in the French Population.</brief_title>
  <acronym>COCANASH</acronym>
  <official_title>Coffee Consumption and NASH in the French Population.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study is to evaluate the effect of coffee consumption on the risk of severe
      liver fibrosis in French patients with NASH.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To compare coffee caffeine consumption in NASH patients with early (F1-2) vs advanced (F3-4) liver fibrosis in univariate analysis and after adjustment for potential confounding factors.</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the correlation between the degree of hepatic fibrosis assessed by elastometry (FibroScan) or the histological stage and the caffeine consumption from coffee in univariate analysis and after adjustment for potential confounding factors.</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the percentage of regular coffee drinkers in NASH patients with early (F1-2) vs advanced (F3-4) liver fibrosis in univariate analysis and after adjustment for potential confounding factors.</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of total caffeine consumption from all types of drinks in patients with NASH with early (F1-2) vs advanced (F3-4) liver fibrosis in univariate analysis and after adjustment for potential confounding factors.</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">228</enrollment>
  <condition>Non Alcoholic Steatohepatitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Non-Alcoholic Steatohepatitis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Any newly diagnosed case of NASH histologically proven graded according to SAF criteria

        Or Metabolic syndrome defined by the IDF 2005 criteria:

          -  waist size&gt; 94cm (men) or&gt; 80cm (women)

          -  and the presence of at least two of the following criteria:

               -  blood pressure: Systolic ≥ 130mmHg OR diastolic ≥ 85 mmHg OR antihypertensive
                  treatment

               -  Triglycerides ≥ 1.5g / L or lipid-lowering therapy

               -  HDL cholesterol &lt;0.4 g / L (men) or &lt;0.5 g / L (women) or lipid-lowering therapy

               -  fasting blood glucose:&gt; 1 g / L or type 2 diabetes AND Hepatic steatosis
                  diagnosed on liver imaging And liver fibrosis (diagnosed with a FibroScan&gt; 6 KPa)

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Viral hepatitis and other chronic liver diseases

          -  Alcohol consumption&gt; 20g / day for women, 30g / day for men

          -  Liver biopsy or FibroScan dating more than 6 months before inclusion.

          -  History of bariatric surgery

          -  Serious psychiatric pathology (psychosis, dementia, severe depression) and patients
             under legal protection (tutelage, guardianship)

          -  Solid cancer or progressive hematology or &lt;2 years (except basal cell carcinoma or
             localized squamous cell carcinoma)

          -  Severe and terminal chronic renal insufficiency (estimated GFR &lt;30mL / min)

          -  Recent myocardial infarction &lt;6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hugues BLONDON, Department head</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre hospitalier de versailles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mélody FORT, Project Manager</last_name>
    <phone>+33 1 39 23 97 76</phone>
    <email>mfort@ch-versailles.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier de Béziers</name>
      <address>
        <city>Béziers</city>
        <zip>34500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Pierre RIPAULT LANDI</last_name>
      <email>marie-pierre.ripault@ch-beziers.fr</email>
    </contact>
    <investigator>
      <last_name>Marie-Pierre RIPAULT LANDI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier Métropole Savoie</name>
      <address>
        <city>Chambéry</city>
        <zip>73011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simona TIRZIU</last_name>
      <email>simona.tirziu@ch-metropole-savoie.fr</email>
    </contact>
    <investigator>
      <last_name>Simona TIRZIU</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Sud Francilien</name>
      <address>
        <city>Corbeil-Essonnes</city>
        <zip>91100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khaldoun ELRIZ</last_name>
      <email>khaldounelriz@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Khaldoun ELRIZ</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Public Sud Oise</name>
      <address>
        <city>Creil</city>
        <zip>60100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Armand GARIOUD</last_name>
      <email>armand.garioud@ghpso.fr</email>
    </contact>
    <investigator>
      <last_name>Armand GARIOUD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal de Créteil</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé HAGEGE</last_name>
      <email>herve.hagege@chicreteil.fr</email>
    </contact>
    <investigator>
      <last_name>Hervé HAGEGE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Gonesse</name>
      <address>
        <city>Gonesse</city>
        <zip>95500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud PAUWELS</last_name>
      <email>arnaud.pauwels@ch-gonesse.fr</email>
    </contact>
    <investigator>
      <last_name>Arnaud PAUWELS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Hyères</name>
      <address>
        <city>Hyères</city>
        <zip>83400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe RENOU</last_name>
      <email>crenou@ch-hyeres.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe RENOU</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Départemental Vendée</name>
      <address>
        <city>La Roche-sur-Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthieu SCHNEE</last_name>
      <email>matthieu.schnee@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Matthieu SCHNEE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Bretagne Sud</name>
      <address>
        <city>Lorient</city>
        <zip>56322</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florent EHRARD</last_name>
      <email>f.ehrhard@ch-bretagne-sud.fr</email>
    </contact>
    <investigator>
      <last_name>Florent EHRARD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de Melun</name>
      <address>
        <city>Melun</city>
        <zip>77011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent TSAKIRIS</last_name>
      <email>laurent.tsakiris@ch-melun.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent TSAKIRIS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier Annecy Genevois</name>
      <address>
        <city>Metz-Tessy</city>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel MAILLARD</last_name>
      <email>emaillard@ch-annecygenevois.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuel MAILLARD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier Montelimar</name>
      <address>
        <city>Montélimar</city>
        <zip>26200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnès PELAQUIER</last_name>
      <email>agnes.pelaquier@free.fr</email>
    </contact>
    <investigator>
      <last_name>Agnès PELAQUIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de Diaconesses</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa POLIN</last_name>
      <email>vpolin@hopital-dcss.org</email>
    </contact>
    <investigator>
      <last_name>Vanessa POLIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Perpignan</name>
      <address>
        <city>Perpignan</city>
        <zip>66000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>André-Jean REMY</last_name>
      <email>andre.remy@ch-perpignan.fr</email>
    </contact>
    <investigator>
      <last_name>André-Jean REMY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Saint Denis</name>
      <address>
        <city>Saint-Denis</city>
        <zip>93200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence SKINAZI</last_name>
      <email>florence.skinazi@st-denis.fr</email>
    </contact>
    <investigator>
      <last_name>Florence SKINAZI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Sens</name>
      <address>
        <city>Sens</city>
        <zip>89100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène COSME</last_name>
      <email>hcosme@ch-sens.fr</email>
    </contact>
    <investigator>
      <last_name>Hélène COSME</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>February 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 14, 2018</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>Dr Hugues Blondon</investigator_full_name>
    <investigator_title>Head of Hepatogastroenterology Service</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

